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Abstract
Introduction: Formyl peptide-receptor 1 and 2 (FPR1 and FPR2) in mice were identified as receptors with contrary affinity
for the PAMP fMLF. Formyl-methionyl-leucyl-phenylalanine is either part of the bacterial membrane and is secreted by the
mitochondria of eukaryotic ceslls during apoptosis. Furthermore FPR1 and 2 are described as highly relevant factors for the
chemotaxis of immune cells. Their role during the acute liver injury has not been investigated yet.
Materials and Methods: Constitutive knockout mice for FPR1 (mFPR1-/-), FPR2 (mFPR2-/-) and wild type (WT) mice were
challenged with LPS i.p. for 3 h and 6 h. Liver and serum were sampled for further analysis.
Results: Liver transaminases were elevated in all mice 3 h and 6 h post LPS stimulation. Gene expression analysis displayed
a reduced expression of the pro-inflammatory cytokines IL-6 and CXCL1 after 3 h in the mFPR1-/- compared to wild type and
mFPR2-/- mice. After 6 h, IL-6, TNF-a and CXCL1 were significantly higher in mice lacking mFPR1 or 2. Consistent to these
findings the numbers of CD11b+ and Ly6G+ immune cells were altered in the livers. The analysis of TLR2 and TLR4 revealed
time and genotype specific changes in theirs gene expression. Additionally, the liver in mFPR1- and mFPR2-deficient mice
seem to be more susceptible to apoptosis by showing a significant higher number of TUNEL+-cells in the liver than WT-mice
and displayed less Ki67-positive nuclei in the liver.
Conclusion: The results suggest a prominent role of FPRs in the regulation of the hepatic inflammatory response after LPS
induced liver injury. Deletion of mFPR1 or mFPR2 leads to deregulation of the inflammatory response compared to WT mice,
associated with more severe liver injury represented by higher levels of transaminases, apoptotic cells and a reduced
regenerative capacity.
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Introduction
The inflammatory response after a liver injury is important for
the induction of liver regeneration [1,2]. Perturbation in mediating
the inflammatory response leads to deregulation of the liver
regeneration and finally to a higher degree of liver injury [1–3].
Failure in resolution of the injury stimulus leads to a chronic liver
injury resulting in chronic liver diseases, e.g. liver fibrosis [3].
During the process of liver injury, parenchymal liver cells undergo
apoptosis [4]. Among the process of apoptosis, small molecules
mediating the cellular damage (Damage associated molecular
patterns/DAMPs) are secreted to the physiological environment
[5]. Among these DAMPs is a small group of molecules which are
evolutionary prokaryotic origin. Those molecules are classified as
the DAMP-subgroup Pathogen-associated-molecular patterns
(PAMPs) [6]. In general PAMPs are functioning as an important
molecule for recognition of pathogens such as bacteria by the
innate immunity [6]. One of these secreted PAMPs is N-formyl-
methionyl-leucyl-phenylalanine peptide (fMLF/fMLP) [7]. The
molecule fMLF is known as an inducer of chemotaxis for
neutrophil granulocytes and monocytes after cellular damage
[5,8]. So far, two sources for fMLF are known. First, the bacterial
cell wall could be identified as a source [9]. Later the mitochondria
were described as a second source for the secretion of fMLF [8].
The release of fMLF is directly related to cellular apoptosis [8].
Known receptors for the fMLF-peptide are the formyl peptide
receptors (FPR). The FPRs belong to the family of G-protein
coupled receptors. Up to now 3 members of the formyl-peptide
receptor family are known. This family is an example for non-
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homology among receptor families. Sequence analysis of FPR1,
FPR2 (FPRL1 in human) and FPR3 (FPRL2 in human) do show a
similarity by 69% (FPR1 to FPRL1) and 56% (FPR1 to FPRL2)
[10]. Furthermore FPR1 shows high affinity towards fMLF,
whereas FPR2 is a low-affinity receptor for fMLF and only high
concentrations of fMLF are able to activate its signalling pathways.
The third receptor FPR3 (FPRL2) shows no affinity for fMLF at
all [11,12]. Also the distribution and the role of these receptors
among tissues and cells are various. FPR1 is a relevant receptor for
the chemotatic movement of neutrophils and monocytes [13].
Neutrophils with a deficiency for FPR1 displayed an unorientated
movement towards a side of injury and failed to reach this area
[5,14]. Besides its presence on the surface of hematopoietic cells
FPR1 and FPR2, as well as theirs murine analogs, is also present
on the surface of various organs (Brain, Liver, Kidney, and
Intestine) [15–17]. The second member of the FPR-Family, FPR2,
also known as FPRL1/LipoxinA4-receptor is poorly chemotatic
and only high concentrations of fMLF induce its signalling
regarding to this PAMP [18]. Furthermore the signalling of both
receptors is highly various and depends on the receptor-ligand
interaction [19]. The role of bacterial translocation in liver
diseases has changed in the last years. Being suggested as a late
stage event [20], it was shown that early bacterial translocation is a
main reason for the establishment of liver fibrosis [21] and the
progress of liver injury and survival of the bacterial infection was
furthermore linked to the bacterial burden [22].
These prior findings suggest a differential role of FPR in the
recruitment of the different leucocyte subtypes and who might
have different functions divided in between tissue resident and
towards injury site recruited cells [23]. Despite the fact of their well
understood role in the chemotatic movement of hematopoietic
cells [5,8], their role in parenchymal cells such as hepatocytes are
poorly understood. Despite the knowledge that these receptors are
both present in murine liver [17], little is known about their role
during the acute bacterial induced hepatitis as well as their impact
in acute liver diseases is not present in the literature yet. We
performed a study using the LPS-model to induce an acute liver
injury in wild type (WT) and constitutive mFPR1- and mFPR2-
knockout mice. Afterwards we performed histological, clinical and




Five 8-10 weeks old wild type, mFPR1-/- [24], mFPR2-/- [25]
C57/Bl6 mice were stimulated with 4mg/Kg bodyweight E. coli
LPS (Sigma-Aldrich, Steinheim, Germany) and kept for 3 h and
6 h. The mFPR1 Mice were a kind gift from Dr. Philip Murphy of
the National Institute for Allergy and Infectious Diseases, NIH
[24]. The mFPR2 knockout mice were generated as described
previously [25]. Littermates were used as controls.
Mice were sacrificed 3 h and 6 h post LPS-stimulation, blood
and liver were removed and preserved for biochemical and
immunohistological assays. After stimulation the mice were kept in
SII-long-cages with access to food and water ad libitum. Blood was
taken retroorbital before sacrifice of the mice. The serum was
separated by centrifugation and stored at 220uC until measure-
ment.
All experiments were performed in accordance to the German
protection of animals act and with permission of the authority of
the federal state North Rhine Westphalia. The study protocol was
approved by the institutional animal care and use committee
(Landesamt für Natur-, Umwelt und Verbraucherschutz (LA-
NUV), Duesseldorf, Reference number: 84-02.04.2013.A246).
RNA-Isolation
Cryopreserved liver tissue was homogenized and RNA was
extracted by using the Nucleospin RNA-II Kit (Macherey-Nagel,
Dueren,Germany). Afterwards 400 ng of total RNA was converted
into cDNA by using the Omniscript reverse transcriptase kit
(Qiagen, Hilden, Germany). All proceedings were performed
according to manufacturers’ guidelines.
Quantitative PCR assay
The gene expression analysis was performed using an ABI 7500
Real-Time PCR (Life Technologies, Darmstadt, Germany).
Genexpression analysis for the murine (ms) genes IL-6, TNF-a,
CXCL1, TLR2, TLR4, mFPR1, mFPR2 and mFPR3 were
performed. The Primers for mFPR1 and mFPR2 were published
previously [26]. Murine qPCR Primers were designed using the
Primer Express 3.0 Software provided by Life Technologies
(Darmstadt, Germany). Specific PCR products were detected by
Sybr-Green and changes in gene expression were analysed by the
DDCT-calculation. GAPDH was used as a housekeeping gene
(Table 1).
Immunohistochemistry for immune cell marker
Formalin fixated paraffin embedded (FFPE) liver samples were
cut into 5 mm strong sections and stained for CD11b (Abcam,
Cambridge, UK, rabbit-anti-mouse) and Ly6G (Affimetrix-
eBioscience, Frankfurt/Main, Germany, rat-anti-mouse). The
primary antibody was used in a dilution of 1:100 and a species
specific secondary antibody with a HRP-conjugate was diluted
1:500 to detect the primary antibody. Visualization was performed
using 3,39-diaminobenzidine tetrahydrochloride (DAB) (Sigma-
Aldrich, Steinheim, Germany). Antigen retrieval was executed
according to manufacturer’s instruction. Nuclei were counter-
stained with Haematoxylin (Sigma-Aldrich, Steinheim, Germany).
For each individual animal/genotype 7 pictures were taken in 100
and 200 fold magnification using an Olympus BX51. The 100 fold
magnification was used for overview whereas the 200 fold
magnification pictures were used for the detailed analysis and
counting of the total CD11b+- or Ly6G+-cells per view field.
For the immunofluorescent staining of CD11b+-cells in the
BDL-model, cryosections of liver tissue were made and stained
with a CD11b-antibody (rat-anti-mouse, eBiosciences, Frankfurt/
Main, Germany) used in a 1:200 dilution. Visualization was
performed using an anti-rat ALEXAFLUOR546 (Life Technol-
ogies, Darmstadt, Germany). Fluorescent microscopy pictures
were taken by an AxioImager Z1 (Carl-Zeiss, Jena).
Tunel staining
FFPE-liver tissue was cut as described above in 5 mm strong
sections. The TUNEL-staining was made according to the
manufacturers’ instruction (Merck-Millipore, Darmstadt, Ger-
many). Visualization was performed using DAB and Nuclei
counterstaining was made with Haematoxylin (Sigma-Aldrich,
Steinheim, Germany).
Ki67-staining
The analysis of the ubiquitous cell cycle marker Ki67 was
performed using the rat-anti mouse Ki67 (Tec3-clone, DAKO,
Hamburg, Germany) in a 1:50 dilution. The detection was
conducted with a secondary, HRP-conjugated anti-rat antibody in
a 1:300 dilution. The visualization was performed with DAB
Formyl Peptide Receptors in Acute Liver Injury
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(Sigma-Aldrich., Steinheim, Germany). Nuclei counterstaining
was performed using Haematoxylin (Sigma-Aldrich Steinheim,
Germany).
Statistics
The datasets were analyzed using the Students T-test and p-
values #0.05 were regarded as significant and indicated in the
respective graph.
Results
FPR-deficiency leads to increment of clinical parameter of
liver injury
Analyses of clinical parameters such as transaminases provide a
quick overview about physiological condition in regard of liver
injury. The alanine-aminotransferase (ALT) and aspartate-amino-
transferase (AST) of WT, mFPR1-/-, mFPR2-/- mice displayed no
initial differences among the different genotypes. After LPS
stimulation for 3 h the transaminases were significantly increased
in mFPR2-/- mice (86 U/L) in comparison to wild type mice
(66 U/L), whereas the mFPR1-/- mice displayed elevation after
3 h LPS administration, but did not reach a level of significant
difference (63 U/L). The analysis of the 6 h time point displayed
that transaminases were significantly upregulated in the serum
derived from mFPR1-/-(296 U/L) or mFPR2-/-(291 U/L) mice
compared to control (76 U/L) mice after LPS-treatment (Fig. 1A
and 1B). The histological analysis of the livers by H&E staining
after LPS-treatment showed an increased inflammatory response
in the livers of all mice in concordance with the elevated levels of
transaminases (Fig. 1C).
Higher presence of inflammatory cells after LPS
treatment
In order to get a better overview of the different immune cell
subtypes infiltrating into the liver, we performed immunohisto-
logical straining for the surface markers CD11b and Ly6G. These
markers identify two relevant cells types involved in promotion of
liver injury. CD11b is known as a marker for activated monocytes
whereas Ly6G is known to detect neutrophil granulocytes
specifically. The immunohistological analysis of CD11b and
Ly6G displays a strong presence of both cell types at 3 h as well
as 6 h post LPS-treatment. At the time point 3 h after LPS the
mFPR1-/- and the mFPR2-/- mice displayed lower number of
CD11b+(Fig. 2A and B) and Ly6G+-cells (Fig. 3A and B) in the
liver compared to wild type. The difference between mFPR1-/-
mice and WT-mice was highly significant either among the
CD11b+- (153632 vs 102624 (p,0,001)) and the Ly6G+-cells
(WT126621 vs mFPR1-/85622 (p,0,001)). Also significantly
lower were the CD11b+-cells (153632 vs 133626 (p,0,05)) and
the number of Ly6g+-cells (126621 vs 106625 (p,0,05)) in the
mFPR2-/- mice in comparison to WT mice. At the later time
point, 6 h after intraperitoneal application of LPS (Fig. 2A and B)
the mFPR1- (196621) and mFPR2-KO (194634) mice displayed
the higher number of CD11b+-cell infiltrates per view field in
comparison to wild type mice (9666). Likewise to the CD11b+-
cells a higher presence of Ly6G+-cells was found in the livers of
mFPR1-/— (160624) and mFPR2-/—mice (144639; Fig. 3A and
B). The numbers of the Ly6G+-cells in the wild type mice (47611)
were significantly lower (WT vs. mFPR1-KO p,0.001; WT vs.
mFPR2-KO p,0.01). Taken together different degrees of
inflammation occurred in regard to the deficiency of either
mFPR1 or mFPR2 as wells as in regard to the temporal
progression of inflammation.
Increased Expression of pro-inflammatory genes
To analyse the inflammatory response further we performed
qPCR analysis from whole liver extracts in order to investigate the
expression of pro-inflammatory genes.
The analysis of cytokine gene expression was contradictory
between the two analysed time points. At 3 h post LPS injection
an increased expression for the IL-6 gene could be detected in the
WT mice compared to the mFPR1-/- mice, who showed a
significantly lower expression of IL-6 mRNA (p,0.01) whereas the
mFPR2-/- mice had a significantly higher expression compared to
WT-mice (p,0.01). At 6 h post LPS injection the expression of
IL-6 was significantly lower in the wild type animals compared to
mFPR1 (p,0.05) and mFPR2-deficient mice (p,0.05). The
expression of TNF-a (Fig. 4B) was significantly increased in the
mFPR1 (p,0.05) and mFPR2-deficient mice (p,0.001) compared
to the WT mice 3 h as well as 6 h after LPS-administration.
Table 1. qPCR Primer.
Gene Sequence Annealing temp-.
IL-6 ms fw AGAAGGAGTGGCTAAGGACCAA 58uC
IL-6 ms rv ACGCACTAGGTTTGCCGAGTA
CXCL1 ms fw CTAGTAGAAGGGTGTTGTGCGAAA 59uC
CXCL1 ms rv AAACACAGCCTCCCACACATG
GAPDH ms fw TGTTGAAGTCACAGGAGACAACCT 58–60uC
GAPDH ms rv AACCTGCCAAGTATGATGACATCA
TNF-a ms fw AGGACCCAGTGTGGGAAGCT 59uC
TNF-a ms rv AAAGAGGAGGCAACAAGGTAGAGA
TLR2 ms fw CCCTTCTCCTGTTGATCTTGCT 58uC
TLR2 ms rv CGCCCACATCATTCTCAGGTA
TLR4 ms fw GCAGAAAATGCCAGGATGATG 59uC
TLR4 ms rv TCTGATCCATGCATTGGTAGGT
mFPR3 fw CCTTTGTTAATTCCAGCCGTCC 60uC
mFPR3 rv TCTCTTTGAGCCAGACTGTGCC
doi:10.1371/journal.pone.0100522.t001
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Correlated to IL-6 gene expression also the cytokine CXCL1
displayed divergent levels of mRNA expression. At 3 h after LPS-
stimulation CXCL1 has a higher expression in WT-mice
compared to mFPR1-/- and mFPR2-/-. The tendency did not
reach a level of significance. At 6 h post LPS injection mFPR1-
knockout and mFPR2-knockout mice displayed a significant
higher expression of CXCL1 compared to wild type mice (fig. 4C).
Altered bacterial recognition after deficiency of mFPR1 or
mFPR2 is suspected
The quantitative analysis of TLR4 and TLR2 expression
displayed a highly different pattern. Toll-like receptor 2 gene
expression is strongly elevated in all mice strains which underwent
LPS-stimulation at time point 3 h. The differences in gene
expression are significant between mFPR2-/- and WT mice, no
significance could be found in comparison of mFPR1-/- and WT
mice. At 6 h post LPS injection the expression of the TLR2 gene is
still induced in all mice strains and displayed a reduction
compared to the 3 h time point and no significant differences
among the different genotypes used in the experiment (Fig. 4D).
The analysis of the Toll-like receptor 4 gene expression (Fig. 4E)
showed a highly interesting pattern. WT mice displayed a
significant higher induction of the TLR4-expression at 3 h after
LPS-stimulation whereas mFPR1 and mFPR2-deficient mice
displayed a significantly lower induction of the TLR4 gene
Figure 1. The clinical and histological analysis after LPS-stimulation includes measuring of ALT (A) and AST (B). The histological
analysis was performed using H&E staining (C). Overview pictures at 0 h were taken in 100-fold magnification, detail microphotographs at 3 h and
6 h post LPS such as infiltrating immune cells are magnified 200-fold (* = p,0.05; *** = p,0.005).
doi:10.1371/journal.pone.0100522.g001
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expression (p,0.05). At 6 h post LPS injection a turnaround was
visible. The mFPR1-/- and mFPR2-/- mice displayed a signifi-
cantly higher expression of the TLR4 gene compared to WT mice
at this time point (p,0.05).
FPR-deficient liver seem to be more sensitive to
cytotoxicity
To understand whether livers lacking mFPR1 and mFPR2 were
more susceptible to pro-apoptotic signalling, a TUNEL-assay was
performed (Fig. 5A and B).
The analysis of the 3 h time point revealed a higher percentage
of TUNEL+-cells in mFPR1 (1.4%) and mFPR2 deficient mice
(2.03%) compared to WT mice (1.2%). At 3 h only mFPR2-/-
mice had a significantly higher number of TUNEL+-cells
detectable in the liver. At the 6 h time point the amount of
TUNEL+-cells was elevated in all mice strains. However,
mFPR1-/- mice (2.53%) and mFPR2-/- mice (2.91%) had both
significantly more apoptotic cells detectable in comparison to WT
mice (1.28%) 6 h after injection of LPS (Fig. 5A and B) (WT vs
mFPR1-/- p,0.05; WT vs mFPR2-/- p,0.01). The mFPR2-/-
mice itself displayed also a non-significant higher tendency for the
number of TUNEL+-cells in comparison to the mFPR1-/- mice at
3 h and 6 h post LPS administration.
Figure 2. To identify the infiltrating immune cells after LPS stimulation according to their surface markers, CD11b was used to
detect infiltrating monocytes and macrophages in the liver (A). Pictures were taken in 200-fold magnification and the CD11b+-cells were
counted. The results were displayed as a graph (B) indicating differences among WT, mFPR1-/- and mFPR2-/- (* = p,0.05; ** = p,0.01; # = p,0.0001).
doi:10.1371/journal.pone.0100522.g002
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Expression profiles of murine FPRs in cholestatic liver
injury in mice
To investigate whether mFPRs are also relevant in other models
of liver injury, we investigated the gene expression of formyl
peptide receptors in a surgical model of cholestatic liver injury (bile
duct ligation/BDL) [27]. We analysed the early time points of
cholestatic liver injury 24 h and 72 h post BDL for changes in
formyl peptide receptor expression (Fig. 6A to C). We were able to
display an increment of mFPR1 expression at 72 h post BDL in
comparison to the basal expression at time point 0 h (Fig. 6A). No
increase was also detected 24 h post BDL. Interestingly the
mFPR2-receptor gene displayed no increase during the early
phase of cholestatic liver injury (Fig. 6B). The formyl peptide
receptor 3 (mFPR3) displayed an elevated gene expression at 24 h
and 72 h after BDL (Fig. 6C). The increase of mFPRs was also
associated with an increase of CD11b+ in the livers of these mice
(Figure S1A and B) during the early phase of cholestatic liver
injury at 24 and 72 h post BDL.
Compensatory liver proliferation after LPS-stimulus
Liver regeneration is a response to compensate the loss of
cellular mass after an injury. To understand whether mFPR1 and
mFPR2 might have an impact on liver regeneration we analysed
the proliferative capacity of livers lacking either mFPR1 or
mFPR2. For this purpose, the ubiquitous cell cycle marker Ki67
was stained at 0 h, 3 h and 6 h post LPS stimulation. The analysis
Figure 3. The second subset of immune cells were analysed by Ly6G-staining. Mainly neutrophil granulocytes were identified as Ly6G+ (A).
Pictures were taken in 200-fold magnification and the Ly6G+-cells were counted. The results were displayed as a graph (B) indicating differences
among WT, mFPR1-/- and mFPR2-/- (* = p,0.05; ** = p,0.01; # = p,0.0001).
doi:10.1371/journal.pone.0100522.g003
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of the staining revealed a lower number of Ki67+-nuclei in the
liver of either mFPR1 or mFPR2-deficient mice in comparison to
wild type mice (Fig. 7 A and B). At 3 h mFPR1-/- (0,89%) and
mFPR2-/- (1,19%) displayed a significantly lower number of
proliferative cells compared to WT mice (1,47%) (mFPR1-/- vs
WT p,0.01, mFPR2-/- vs WT; p,0.05). At 6 h post LPS
administration the differences between WT (1,42) and mFPR1-/-
(1,20%) were still present but did not reached a level of
significance. The significant lower proliferation of mFPR-deficient
mice (0,99%) compared to WT mice was still present at this time
point (p,0.05).
Figure 4. To better understand mechanism underlying the infiltration of immune cells into the liver of mFPR-deficient mice the
gene expression of the pro-inflammatory cytokines IL-6 (A), TNF-a (B), CXCL1 (C), TLR2 (D) and TLR4 (E) were analyzed by qPCR.
Changes in gene expression were related to GAPDH as a housekeeping gene. (* = p,0.05; ** = p,0.01; # = p,0.0001.)
doi:10.1371/journal.pone.0100522.g004
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Discussion
Formyl peptide receptors 1 and 2 are known to function as
important mediators of chemotaxis of hematopoietic cells [28,29].
The receptors interact with a menagerie of structurally diverse
pro- and anti-inflammatory ligands associated with different
diseases, including amyloidosis, Alzheimer’s disease, prion disease
and HIV [29–31]. After activation by theirs respective ligands
either fMLF or Lipoxin A4, FPRs induce various effects to
haematopoietic cells such as chemotaxis or release of superoxide
[29,32,33]. Furthermore it was shown that deficiency of FPR1 in
neutrophils leads to disorientation and inability to migrate to an
area of injury [14] e.g. the liver. So far the knowledge about their
role in parenchymal liver cells is marginal. For FPR2 it has to be
pointed out, that it plays a promiscuous role. On the one hand it
can interact with pro-inflammatory ligand such as fMLF and
Cramp [34] on the other hand it also interacts with anti-
inflammatory ligands with seem to have a more prominent effect
in activation of FPR2 downstream signalling [35,36]. Previous
work about regulation of liver inflammation after an injury pointed
out the importance of maintaining liver homeostasis and to avoid
chronic inflammatory liver injury and in the final stages chronic
liver diseases [20,37,38].
We compared the effect of mFPR1 and mFPR2 deficiency after
LPS-stimulation, mimicking a bacterial mediated liver injury. The
initial analysis of the transaminases AS and ALT (Fig. 1A and B)
from the LPS treated mice strains displayed at 3 h post LPS no
difference among the wild type and mFPR1-/- mice. The
Figure 5. For determination of the liver injury FFPE-section were stained for DNA-strand breaks using a TUNEL-assay. Tunel+-cells
were counted. Counterstaining was perfomed using Haematoxylin (A). Pictures were taken in 200 fold magnification. Results displaying an increase of
TUNEL+-cells in regard to mFPR1 and mFPR2-deficiency are shown as a Graph (B). (* = p,0.05; ** = p,0.01.)
doi:10.1371/journal.pone.0100522.g005
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mFPR2-/- mice displayed a significant higher level of ALT in the
serum. At the later 6 h time point, both, mFPR1-/- and mFPR2-/-,
displayed a significantly higher Level of ALT. For AST a slightly
different pattern appears. Wild type mice had the highest levels of
AST detectable in the serum compared to mFPR1 and mFPR2-
deficient mice. 6 h post LPS the mFPR1 and mFPR2 knockout
mice displayed significant higher levels of AST in the serum.
These findings support a protective role for formyl peptide
receptors during progression of LPS induced liver injury. The
histological analysis after LPS-stimulation revealed a differential
recruitment of immune cells in a time and genotype dependent
manner. The cytokine IL-6 is not only known as a recruiting
molecule for immune cells. It is described as one of the main
drivers of hepatoprotection during liver injury [39], which
mediates hepatoprotection against FAS-induced apoptosis [40]
as well as TNF-a induced apoptosis in the liver [41]. The
differential expression of IL-6, which is described as one of the
most critical regulators of the immune response in the liver
suggest, that mFPR1 mediated signalling is involved in the
regulation of the early phase of inflammatory response in the liver
and as a possible modulator of IL-6 signalling. A similar pattern is
shown by the analysis of the expression of CXCL1 which
correlates with the IL-6 expression [42]. At the 6h time point
increased migration of immune cells to the liver of mFPR1- and
mFPR2-deficient mice. The more detailed analysis of those liver
infiltrating cells was done by staining FFPE-liver tissues with
antibodies for myeoloid cells (CD11b) or neutrophils (Ly6G). In
comparison to wild type mice monocytes and neutrophils
displayed a stronger presence in the livers of FPR1-/- and
FPR2-/- mice 6 h after LPS stimulation. Interestingly mFPR2-/-
mice showed a lower tendency regarding the number of Ly6G+-
cells visible per view field. The closest explanation for this
phenomenon is the link to the neutrophil recruiting cytokine
CXCL1 (CXCL1) which showed the same tendency at least on
mRNA level at 3 h and at 6 h post LPS-stimulation. Differential
roles for mFPR1 and mFPR2 regarding immune cell homing is
not excluded for granulocytes and supported by the literature
[14,43]. It was shown recently, that FPR1 regulates the anti-
inflammatory response [44]. Whether this response is correlated to
the IL-6 signalling remains to be investigated.
A further finding of the regulation of the anti-inflammatory
response is visible for other PAMP-receptors such as TLR4 and
TLR2 (Fig. 4D and E). The analysis of theirs expression by qPCR
reveals an increment in mFPR1 and mFPR2-deficient animals for
TLR2 3 h and 6 h post LPS. TLR4 showed a high expression in
WT animals at 3 h and a significantly reduced expression in
mFPR1 and mFPR2 deficient mice. On the other hand 6 h post
LPS stimulation the TLR4 gene is significantly higher expressed in
the mFPR1 and mFPR2-knockout mice. This leads to the
conclusion that pathogen recognition might be delayed in the
Figure 6. The Expression of the three mFPRs mFPR1 (A), mFPR2 (B) and mFPR3 (C) was analysed by qPCR and the gene expression
was related to GAPDH. For the analysis of inflammation in the BDL-model immune cells were stained for CD11b-positivity. Graphical score for the
amount of CD11b+-cells in the liver displays an increase over time. The cells are displayed as numbers per view field (D).
doi:10.1371/journal.pone.0100522.g006
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formyl peptide-receptor deficient mice and that both receptors
contribute to this recognition and are essential for a stringent and
correct procedure of this. This furthermore supports an immuno-
modulatory function of FPRs, which might not be exclusively
provided by hematopoietic cells but also by parenchymal liver cells
e.g. hepatocytes and hepatic stellate cells. In contrast to previous
publications [45], the number of apoptotic cells in the liver of
mFPR2-/- mice was the highest of all mice strains used in this
study. The anti-apoptotic capabilities of FPR2/FPRL1 in primary
human neutrophils are controversially discussed. Previous obser-
vations by Nagaoka et al. revealed that FPR2 is protective together
with the P2X7 receptor [46]. It was shown later that the distinct
presence of Serum amyloid A (SAA), activates a protective
signalling pathway which is P2X7 dependent, but FPR2/FPRL1
independent [47]. So far, the participation of mFPR2 in the
regulation of the liver inflammation remains to be investigated in
detail. A better explanation for the higher rate of apoptosis is the
stronger expression of the pro-inflammatory and pro-apoptotic
cytokine TNF-a, a cytokine with pro-apoptotic abilities. It is
significantly stronger expressed in either mFPR1-/- and mFPR2-/-
mice in comparison to WT-mice. Furthermore these findings
suggest a specific anti-apoptotic signalling of mFPR2 towards
TNF-a induced pro-apoptotic signalling. Stimulation experiments
using a combination of fMLF and pharmacological inhibitors for
p38 and MEK resulted in reduced chemotaxis, adhesion and
release of superoxide by neutrophils [33] supporting a hypothesis
of intracellular pathway modulation by FPRs.
Figure 7. To investigate liver proliferation FFPE-sections were stained with the universal cell cycle marker Ki67. At 3 h and 6 h post
LPS Ki67+-nuclei were counted and analyzed as percentage of proliferative cells. Photomicrographs were taken at 200-fold and representative images
are shown. Ki67+-nuclei are indicated by arrows (* = p,0.05; ** = p,0.01).
doi:10.1371/journal.pone.0100522.g007
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The investigation of liver proliferation to compensate the loss of
liver mass, displayed an impairment of regenerative capacity in
mFPR1 and mFPR2-deficient mice. Both genotypes showed a
lower proliferation at 3 h and 6 h post LPS-induced liver injury,
suggesting critical involvement of mFPR1 and mFPR2 in liver
regeneration. Recent studies of liver regeneration showed that
other member of the GPCR family especially the cannabinoid
type 1 receptors support these findings. Furthermore, it puts the
Ca2+-Signalling into the focus of attention and suggests an
involvement of Ca2+ induced signalling in the mediation of cell
cycle progression [48,49].
The analysis of the mRNA expression of mFPR1-3 in the BDL
model shows an increase of mFPR1 and mFPR3 gene expression
in concordance with the number of infiltrating monocytes in the
liver (Fig. 6A–C, Fig S1 A&B). This finding suggests a relevant role
for FPRs in the regulation of the inflammatory response of the
liver after an injury stimulus. Earlier findings indicate a relevant
role of mFPRs in the clearance of the sepsis [14]. A previous
publication of our group linked functional signalling cascades to a
pro-survival phenotype in a murine model of acute biliary injury
[22]. The analysis of liver inflammation in the cholestatic liver
injury model for the variation of mFPR expression at the time
point 24 h and 72 h post BDL suggests that a coordinated
presence and expression is important for maintaining the
equilibrium of inflammation also to avoid a chronic inflammation
which leads to liver fibrosis.
The consequences of FPR deficiency in an acute model of liver
injury seem to be a loss of anti-apoptotic and anti-inflammatory
capabilities. Our findings suggest a pro-survival, anti-inflammatory
role during an acute LPS-induced liver injury. This is in
concordance with previous findings suggesting a positive role for
FPR during the phase of acute injury [14,50]. How these signals
are regulated by FPRs remains unclear as well as an interconnec-
tion between FPR mediated signalling pathways towards pro-
inflammatory pathways such as IL-6 or pro-apoptotic pathways
such as TNF-a remain to be investigated.
Furthermore, the role of FPRs in progression of chronic
inflammatory liver diseases is not understood and ought to be
investigated. Based on recent investigations FPR expression could
also be shown on natural killer cells [43] suggest that the effects of
the formyl peptide receptors is not limited to the innate
inflammatory response. A more detailed analysis of the immune
cell subtypes after deletion of mFPRs will show whether there is a
not only a disorientation of neutrophils [14] but also a change in
other myeloid and lymphoid leukocyte populations. This extends
the prior findings e.g. in neuronal tissue [26] and the immune cell
migration. Whether our findings show the cause of inflammation
or the response only is hard to define. It is important to point out
that formyl peptide receptors do play a prominent role in the
mediation of the inflammatory response in the liver and that they
are involved in the mediation of pathogen recognition. This results
in a delayed expression of TLR4. As a consequence of this delay
we also suggest a differential role for mFPR1 and mFPR2. The
lack of mFPR1 leads to disruption of the early inflammatory
homeostasis. This disequilibrium leads to an increased inflamma-
tory response at the later stages of inflammation. Murine FPR2
deficiency seems to be more related to a lack of anti apoptotic and
hepatoprotective function. This leads to a stronger expression of
pro inflammatory cytokines which results in a higher grade of liver
inflammation associated with a higher number of apoptotic cells in
the liver and a reduced regenerative capacity. Furthermore,
analysis regarding the influence of fMLF and its antagonists
displayed a strong influence e.g. on osteogenesis [51] by regulating
the differentiation of progenitor cells via the ERK-pathway.
Progenitor cells also do play a critical role in the liver and their
function during liver regeneration is intensively discussed [52,53].
If fMLF also has an influence on this type of progenitor cells and
by this also on the liver regeneration remains to be investigated in
detail. Future investigations of our group will aim on a more
detailed analysis of formyl peptide receptor signalling pathways in
regard to pathogenesis of acute and chronic inflammatory liver
diseases such as acute liver failure, NASH (Non-alcoholic-steato-
hepatitis) and liver fibrosis.
Taken together both receptors are important to maintain a
functional response to LPS induced liver injury. Furthermore our
data suggests that mFPR1 and mFPR2 might also be involved in
processes such as liver regeneration and might also have relevance
not only during the acute liver injury, but also during chronic liver
injury. Further experiments will provide prove to this hypothesis.
Supporting Information
Figure S1 Immunofluorescent staining for CD11b re-
veals an increase over time after BDL. CD11b+-cells were
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